The FDA has approved Janssen’s antidepressant nasal spray ... with treatment-resistant depression (TRD) who have cycled through multiple treatments without relief. Spravato (esketamine) has ...
In April, she’d begun to use a topical nasal-spray decongestant. The over-the-counter (OTC) drug worked like a charm. By summer, she was still using the spray daily. Yet it was helping for ...
Summary: Researchers have developed a promising nasal spray therapy targeting neuroinflammation in Alzheimer’s disease, potentially delaying its progression by over a decade. Using extracellular ...
A new nasal spray therapy by Texas A&M researchers shows promise in delaying Alzheimer’s progression by targeting brain inflammation and reducing harmful proteins. Tested in animal models, it may ...
Johnson & Johnson has priced its new Spravato nasal spray for treatment-resistant depression ... has published its final report on Spravato (esketamine) and says the drug would need to be between ...